nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.799	1	CbGaD
Oxazepam—GABRQ—forebrain—attention deficit hyperactivity disorder	0.00225	0.0342	CbGeAlD
Oxazepam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.00188	0.0286	CbGeAlD
Oxazepam—GABRD—forebrain—attention deficit hyperactivity disorder	0.00164	0.0248	CbGeAlD
Oxazepam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00157	0.0239	CbGeAlD
Oxazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00152	0.0231	CbGeAlD
Oxazepam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00138	0.0209	CbGeAlD
Oxazepam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00122	0.0186	CbGeAlD
Oxazepam—GABRQ—nervous system—attention deficit hyperactivity disorder	0.00122	0.0186	CbGeAlD
Oxazepam—GABRQ—central nervous system—attention deficit hyperactivity disorder	0.00118	0.0179	CbGeAlD
Oxazepam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00115	0.0175	CbGeAlD
Oxazepam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00115	0.0175	CbGeAlD
Oxazepam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00108	0.0164	CbGeAlD
Oxazepam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00107	0.0163	CbGeAlD
Oxazepam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00106	0.0161	CbGeAlD
Oxazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00105	0.016	CbGeAlD
Oxazepam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00104	0.0158	CbGeAlD
Oxazepam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00103	0.0157	CbGeAlD
Oxazepam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00102	0.0155	CbGeAlD
Oxazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00102	0.0154	CbGeAlD
Oxazepam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00101	0.0153	CbGeAlD
Oxazepam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.000999	0.0152	CbGeAlD
Oxazepam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.000983	0.0149	CbGeAlD
Oxazepam—GABRQ—brain—attention deficit hyperactivity disorder	0.000936	0.0142	CbGeAlD
Oxazepam—Bromazepam—GABRQ—attention deficit hyperactivity disorder	0.000925	0.125	CrCbGaD
Oxazepam—GABRD—nervous system—attention deficit hyperactivity disorder	0.000888	0.0135	CbGeAlD
Oxazepam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.000885	0.0134	CbGeAlD
Oxazepam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.000855	0.013	CbGeAlD
Oxazepam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.000854	0.013	CbGeAlD
Oxazepam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.00085	0.0129	CbGeAlD
Oxazepam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.000835	0.0127	CbGeAlD
Oxazepam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.000829	0.0126	CbGeAlD
Oxazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.000824	0.0125	CbGeAlD
Oxazepam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.000823	0.0125	CbGeAlD
Oxazepam—GABRG3—brain—attention deficit hyperactivity disorder	0.000819	0.0124	CbGeAlD
Oxazepam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.000818	0.0124	CbGeAlD
Oxazepam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.000804	0.0122	CbGeAlD
Oxazepam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.000799	0.0121	CbGeAlD
Oxazepam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.000798	0.0121	CbGeAlD
Oxazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.000793	0.012	CbGeAlD
Oxazepam—GABRR1—brain—attention deficit hyperactivity disorder	0.000781	0.0119	CbGeAlD
Oxazepam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.00078	0.0118	CbGeAlD
Oxazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.000767	0.0116	CbGeAlD
Oxazepam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.000761	0.0116	CbGeAlD
Oxazepam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.000761	0.0116	CbGeAlD
Oxazepam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.000748	0.0114	CbGeAlD
Oxazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.000739	0.0112	CbGeAlD
Oxazepam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00072	0.0109	CbGeAlD
Oxazepam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.000704	0.0107	CbGeAlD
Oxazepam—GABRD—brain—attention deficit hyperactivity disorder	0.000679	0.0103	CbGeAlD
Oxazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.000672	0.0102	CbGeAlD
Oxazepam—GABRG1—brain—attention deficit hyperactivity disorder	0.000653	0.00992	CbGeAlD
Oxazepam—GABRA6—brain—attention deficit hyperactivity disorder	0.000649	0.00986	CbGeAlD
Oxazepam—GABRB1—brain—attention deficit hyperactivity disorder	0.000633	0.00962	CbGeAlD
Oxazepam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.000633	0.0858	CrCbGaD
Oxazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.00063	0.00956	CbGeAlD
Oxazepam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.000629	0.0852	CrCbGaD
Oxazepam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.000625	0.0095	CbGeAlD
Oxazepam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.000625	0.0095	CbGeAlD
Oxazepam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.000602	0.00914	CbGeAlD
Oxazepam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.000602	0.00914	CbGeAlD
Oxazepam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.000589	0.00894	CbGeAlD
Oxazepam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.000589	0.00894	CbGeAlD
Oxazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.000586	0.0089	CbGeAlD
Oxazepam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.000584	0.00887	CbGeAlD
Oxazepam—GABRA4—brain—attention deficit hyperactivity disorder	0.000571	0.00868	CbGeAlD
Oxazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.000571	0.00868	CbGeAlD
Oxazepam—GABRE—nervous system—attention deficit hyperactivity disorder	0.000567	0.0086	CbGeAlD
Oxazepam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.000558	0.0757	CrCbGaD
Oxazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.000552	0.00838	CbGeAlD
Oxazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00055	0.00835	CbGeAlD
Oxazepam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.000546	0.00828	CbGeAlD
Oxazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000538	0.00816	CbGeAlD
Oxazepam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.000534	0.0725	CrCbGaD
Oxazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.000532	0.00807	CbGeAlD
Oxazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00052	0.00789	CbGeAlD
Oxazepam—Midazolam—GABRQ—attention deficit hyperactivity disorder	0.000518	0.0703	CrCbGaD
Oxazepam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.00048	0.00729	CbGeAlD
Oxazepam—GABRB2—brain—attention deficit hyperactivity disorder	0.000478	0.00726	CbGeAlD
Oxazepam—GABRG2—brain—attention deficit hyperactivity disorder	0.000478	0.00726	CbGeAlD
Oxazepam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.000462	0.00702	CbGeAlD
Oxazepam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.000452	0.00686	CbGeAlD
Oxazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.000444	0.0602	CrCbGaD
Oxazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.000437	0.00663	CbGeAlD
Oxazepam—GABRE—brain—attention deficit hyperactivity disorder	0.000433	0.00658	CbGeAlD
Oxazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.000422	0.00641	CbGeAlD
Oxazepam—GABRB3—brain—attention deficit hyperactivity disorder	0.000367	0.00557	CbGeAlD
Oxazepam—Clozapine—HRH3—attention deficit hyperactivity disorder	0.000321	0.0435	CrCbGaD
Oxazepam—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.000293	0.0397	CrCbGaD
Oxazepam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000246	0.00373	CbGeAlD
Oxazepam—Amoxapine—DRD4—attention deficit hyperactivity disorder	0.000242	0.0328	CrCbGaD
Oxazepam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000237	0.00359	CbGeAlD
Oxazepam—Amoxapine—HTR1B—attention deficit hyperactivity disorder	0.000215	0.0292	CrCbGaD
Oxazepam—Amoxapine—DRD3—attention deficit hyperactivity disorder	0.000209	0.0283	CrCbGaD
Oxazepam—Amoxapine—DRD1—attention deficit hyperactivity disorder	0.000205	0.0278	CrCbGaD
Oxazepam—Amoxapine—SLC6A3—attention deficit hyperactivity disorder	0.000194	0.0263	CrCbGaD
Oxazepam—Amoxapine—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.0258	CrCbGaD
Oxazepam—Clozapine—DRD4—attention deficit hyperactivity disorder	0.000159	0.0215	CrCbGaD
Oxazepam—Amoxapine—SLC6A4—attention deficit hyperactivity disorder	0.000145	0.0197	CrCbGaD
Oxazepam—Amoxapine—DRD2—attention deficit hyperactivity disorder	0.000144	0.0196	CrCbGaD
Oxazepam—Clozapine—HTR1B—attention deficit hyperactivity disorder	0.000141	0.0191	CrCbGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000137	0.00107	CbGpPWpGaD
Oxazepam—Clozapine—DRD3—attention deficit hyperactivity disorder	0.000137	0.0186	CrCbGaD
Oxazepam—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000135	0.00105	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000135	0.00105	CbGpPWpGaD
Oxazepam—Clozapine—DRD1—attention deficit hyperactivity disorder	0.000134	0.0182	CrCbGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000134	0.00105	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000134	0.00104	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000133	0.00104	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000133	0.00104	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000133	0.00104	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000131	0.00102	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000131	0.00102	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000128	0.001	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000128	0.000999	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000128	0.000999	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.000995	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000128	0.000994	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000127	0.000992	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000127	0.000992	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000126	0.000982	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000126	0.000979	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000125	0.000978	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000125	0.000978	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000125	0.000976	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000125	0.000975	CbGpPWpGaD
Oxazepam—Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.0169	CrCbGaD
Oxazepam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000125	0.000972	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000124	0.00097	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000124	0.000968	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000968	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000124	0.000967	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000964	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000123	0.000958	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000123	0.000957	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000122	0.000953	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000122	0.000951	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000121	0.000947	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00012	0.000937	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000119	0.00093	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000119	0.00093	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000119	0.000924	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000924	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000117	0.000914	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000117	0.000914	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000117	0.000913	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000908	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000116	0.000907	CbGpPWpGaD
Oxazepam—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000116	0.000906	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000116	0.000906	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000903	CbGpPWpGaD
Oxazepam—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000115	0.0009	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000115	0.000894	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000115	0.000894	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000114	0.000892	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000114	0.00089	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000114	0.000887	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000114	0.000886	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000113	0.000885	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000113	0.00088	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000112	0.000874	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000112	0.000873	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000112	0.000871	CbGpPWpGaD
Oxazepam—Amoxapine—HTR2A—attention deficit hyperactivity disorder	0.000112	0.0151	CrCbGaD
Oxazepam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000112	0.00087	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000111	0.000865	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00011	0.000859	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000109	0.000853	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000108	0.000844	CbGpPWpGaD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000108	0.000843	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000842	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000107	0.000837	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000107	0.000833	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000107	0.000831	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000107	0.000831	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000107	0.000831	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000106	0.000829	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000106	0.000827	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000106	0.000826	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000106	0.000826	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000106	0.000824	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000105	0.000822	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000105	0.00082	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000105	0.000818	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000105	0.000817	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000104	0.000809	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000103	0.000805	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000102	0.000799	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000102	0.000795	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000102	0.000793	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000102	0.000793	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0001	0.00078	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.84e-05	0.000767	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.77e-05	0.000762	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	9.75e-05	0.00076	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.75e-05	0.00076	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.65e-05	0.000752	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.63e-05	0.00075	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.6e-05	0.000748	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.58e-05	0.000747	CbGpPWpGaD
Oxazepam—UGT1A9—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.51e-05	0.000742	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.51e-05	0.000741	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.48e-05	0.000739	CbGpPWpGaD
Oxazepam—Clozapine—DRD2—attention deficit hyperactivity disorder	9.47e-05	0.0128	CrCbGaD
Oxazepam—UGT1A9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.45e-05	0.000736	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.38e-05	0.000732	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.37e-05	0.000731	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	9.34e-05	0.000728	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.31e-05	0.000726	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.3e-05	0.000725	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.2e-05	0.000717	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.14e-05	0.000713	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.14e-05	0.000712	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.08e-05	0.000708	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	9.07e-05	0.000707	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.04e-05	0.000705	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	9.01e-05	0.000703	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.99e-05	0.000701	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.98e-05	0.0007	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.92e-05	0.000696	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	8.92e-05	0.000695	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.82e-05	0.000688	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	8.78e-05	0.000685	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.76e-05	0.000683	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.72e-05	0.00068	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.69e-05	0.000678	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.65e-05	0.000674	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.59e-05	0.00067	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.45e-05	0.000658	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	8.39e-05	0.000654	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.29e-05	0.000647	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	8.19e-05	0.000638	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.15e-05	0.000635	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.13e-05	0.000634	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.12e-05	0.000633	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.1e-05	0.000631	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	8.08e-05	0.00063	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.02e-05	0.000626	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	8e-05	0.000624	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.95e-05	0.00062	CbGpPWpGaD
Oxazepam—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.94e-05	0.000619	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.89e-05	0.000615	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	7.8e-05	0.000608	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	7.71e-05	0.000601	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	7.66e-05	0.000597	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	7.62e-05	0.000594	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.39e-05	0.000576	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.34e-05	0.000572	CbGpPWpGaD
Oxazepam—Clozapine—HTR2A—attention deficit hyperactivity disorder	7.32e-05	0.00992	CrCbGaD
Oxazepam—UGT2B15—Metabolism—TPH2—attention deficit hyperactivity disorder	7.26e-05	0.000566	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.26e-05	0.000566	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	7.18e-05	0.00056	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—DPYD—attention deficit hyperactivity disorder	7.14e-05	0.000557	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.13e-05	0.000556	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.07e-05	0.000551	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	7.05e-05	0.00055	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	7e-05	0.000546	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	6.95e-05	0.000542	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	6.93e-05	0.00054	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	6.88e-05	0.000537	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.88e-05	0.000536	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.84e-05	0.000533	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	6.76e-05	0.000527	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.74e-05	0.000526	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.74e-05	0.000526	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.71e-05	0.000523	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.64e-05	0.000517	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	5.91e-05	0.000461	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.87e-05	0.000457	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	5.83e-05	0.000455	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.8e-05	0.000452	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.78e-05	0.000451	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.74e-05	0.000448	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	5.71e-05	0.000445	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.7e-05	0.000445	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TPH2—attention deficit hyperactivity disorder	5.61e-05	0.000437	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.61e-05	0.000437	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.55e-05	0.000433	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.52e-05	0.00043	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—DPYD—attention deficit hyperactivity disorder	5.52e-05	0.00043	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.47e-05	0.000426	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.18e-05	0.000403	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.13e-05	0.0004	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.11e-05	0.000398	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	5.03e-05	0.000392	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.79e-05	0.000373	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.67e-05	0.000364	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.54e-05	0.000354	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.48e-05	0.000349	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.46e-05	0.000348	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—COMT—attention deficit hyperactivity disorder	4.4e-05	0.000343	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.38e-05	0.000342	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—MAOA—attention deficit hyperactivity disorder	4.37e-05	0.00034	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.35e-05	0.000339	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.27e-05	0.000333	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.27e-05	0.000333	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.03e-05	0.000315	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	3.93e-05	0.000307	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.89e-05	0.000303	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.74e-05	0.000291	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—COMT—attention deficit hyperactivity disorder	3.4e-05	0.000265	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—MAOA—attention deficit hyperactivity disorder	3.37e-05	0.000263	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	3.3e-05	0.000258	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.3e-05	0.000258	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.27e-05	0.000255	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	3.25e-05	0.000253	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.02e-05	0.000236	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.69e-05	0.00021	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.69e-05	0.000209	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.69e-05	0.000209	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.67e-05	0.000208	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.65e-05	0.000207	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.64e-05	0.000206	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—DPYD—attention deficit hyperactivity disorder	2.64e-05	0.000206	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.52e-05	0.000196	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.46e-05	0.000191	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.37e-05	0.000184	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	2.26e-05	0.000176	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.26e-05	0.000176	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	2.22e-05	0.000173	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.15e-05	0.000167	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.07e-05	0.000161	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.04e-05	0.000159	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	2e-05	0.000156	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.99e-05	0.000155	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—EP300—attention deficit hyperactivity disorder	1.89e-05	0.000147	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.81e-05	0.000141	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.72e-05	0.000134	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	1.63e-05	0.000127	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.63e-05	0.000127	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—COMT—attention deficit hyperactivity disorder	1.63e-05	0.000127	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.62e-05	0.000126	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	1.61e-05	0.000125	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.57e-05	0.000122	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.49e-05	0.000116	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—EP300—attention deficit hyperactivity disorder	1.46e-05	0.000114	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	1.37e-05	0.000107	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.36e-05	0.000106	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.31e-05	0.000102	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	9.69e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.1e-05	8.57e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	9.89e-06	7.71e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	9.82e-06	7.66e-05	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	8.59e-06	6.69e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.59e-06	5.92e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.59e-06	5.92e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.47e-06	5.82e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—EP300—attention deficit hyperactivity disorder	6.98e-06	5.44e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.94e-06	5.41e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.07e-06	4.73e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	5.87e-06	4.57e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.78e-06	4.5e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.6e-06	3.58e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.57e-06	3.56e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.24e-06	3.31e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.97e-06	1.54e-05	CbGpPWpGaD
